ImmunityBio
The Director of Regulatory CMC oversees the global Chemistry, Manufacturing, and Control regulatory strategy for investigational and marketed products at ImmunityBio. This role involves managing a team to prepare and review CMC modules in eCTD format for Health Authority submissions while collaborating with cross-functional experts. The position is critical for developing submission strategies, handling quality section content, and ensuring compliance with regional regulatory requirements.
Headquarters
San Diego, California, United States
Company Size
501-1000 employees
Founded
2014
We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.
ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data
3 days ago
Is It Time To Reassess ImmunityBio (IBRX) After Its Recent Share Price Surge
2 days ago
ImmunityBio’s Stock Sees a Huge Boost
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ImmunityBio.
Right around the average for this role
ImmunityBio (NASDAQ:IBRX) Stock Price Up 3.2% - What's Next?
1 day ago
Senior Manager/Associate Director, Regulatory Affairs CMC
shionogi
Regulatory CMC Lead
Relay Therapeutics
Senior CMC Regulatory Affairs (RA) Manager
AbCellera
Senior Associate, Regulatory Affairs CMC
Iovance Biotherapeutics
Regulatory Affairs Manager/Senior Manager, CMC
Novartis
Associate Director, Regulatory CMC
Praxis Precision Medicines, Inc.